Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity - Multiple Sclerosis and Related Disorders
A New Schedule of CHOP/Rituximab Plus Granulocyte-Macrophage Colony-Stimulating Factor Is an Effective Rescue for Patients with Aggressive Lymphoma Failing Autologous Stem Cell Transplantation - Biology of Blood and Marrow Transplantation
טוויטר \ ERA - European Renal Association בטוויטר: "Pierre Ronco. Rituximab in membranous nephropathy. MENTOR-trial. Rtx is as effective as Cs in inducing C/PR #ERAEDTA18 #RITUXIMAB #RtxGlomerulardisease https://t.co/Ein148uebM"
Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies | Inflammation and Regeneration | Full Text
Increase in the density of CD20 improves the efficacy of rituximab (... | Download Scientific Diagram
How does ocrelizumab differ from rituximab? - Quora
Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX. - ppt download
Percentage of apoptosis in untreated versus rituximab (RTX)-treated... | Download Scientific Diagram
Rituximab (RTX) treatment correlates with significant attenuation of... | Download Scientific Diagram
Rituximab (RTX) stimulation induces SHP-1 recruitment to CD16 z chain.... | Download Scientific Diagram
Non-Hodgkin Lymphoma | Encyclopedia MDPI
specificity for rituximab (rtx) and infliximab (ifx) peptides of the... | Download Scientific Diagram
Internalization of rituximab (RTX) to a highly variable extent,... | Download Scientific Diagram
Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis - The Journal of Allergy and Clinical Immunology: In Practice
Rituximab (RTX)- or ofatumumab (OFA)-opsonized target interaction... | Download Scientific Diagram
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Immunosuppressive therapy with rituximab in common variable immunodeficiency | Clinical and Molecular Allergy | Full Text
Rituximab (RTX)-induces in vitro complement-dependent cytotoxicity... | Download Scientific Diagram
Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo | Leukemia
Activatory and Inhibitory Fcγ Receptors Augment Rituximab-mediated Internalization of CD20 Independent of Signaling via the Cytoplasmic Domain* - Journal of Biological Chemistry
Rituximab-Monotherapie im Vergleich zur Kombination von RTX mit Methotrexat oder Leflunomid – eine deutsche Studie zur Therapie der aktiven RA mit RTX in der täglichen Routine – rheuma-online
Rituximab Prolongs the Time to Relapse in Patients with Immune Thrombotic Thrombocytopenic Purpura: Analysis of Off-Label Use in Japan - ISTH Congress Abstracts
Level of rituximab (RTX) and B cells after initiation of RTX therapy in... | Download Scientific Diagram
Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura - The Journal of Pediatrics
Efficacy and safety of different dosages of rituximab for refractory
ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients - ACR Meeting Abstracts
